Trial Profile
Clinical efficacy and safety of Naftopidil treatment for the patients with benign prostatic hyperplasia: A prospective, open-label, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Naftopidil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 09 Mar 2017 New trial record